Lionel Fontao Selected Research

Lionel Fontao Research Topics

Disease

6	Bullous Pemphigoid (Pemphigoid) 10/2023 - 06/2003
3	Systemic Scleroderma (Systemic Sclerosis) 01/2016 - 05/2013
3	Fibrosis (Cirrhosis) 01/2016 - 05/2013
2	Neurosyphilis (General Paresis of the Insane) 12/2023 - 01/2022
2	COVID-19 10/2020 - 07/2020
2	Melanoma (Melanoma, Malignant) 05/2018 - 07/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2023
1	Tinea (Ringworm) 07/2023
1	Pemphigoid Gestationis (Herpes Gestationis) 01/2023
1	Neoplasms (Cancer) 05/2018
1	Necrosis 01/2016
1	Wounds and Injuries (Trauma) 01/2015
1	Pain (Aches) 01/2015
1	Ulcer 01/2015
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 11/2014
1	Atrophy 01/2014
1	Localized Scleroderma (Morphea) 01/2014
1	Inflammation (Inflammations) 05/2013
1	Chloracne 01/2012
1	Hamartoma 01/2012
1	Poisoning 01/2012
1	Netherton Syndrome 09/2011
1	Muscular Dystrophies (Muscular Dystrophy) 05/2011
1	Pulmonary Embolism 07/2008
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2008
1	Acute Coronary Syndrome 07/2008
1	Stroke (Strokes) 07/2008
1	Autoimmune Diseases (Autoimmune Disease) 06/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2007
1	Cardiomyopathies (Cardiomyopathy) 12/2006
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2004

Drug/Important Bio-Agent (IBA)

5	Immunoglobulin G (IgG)IBA 12/2023 - 07/2008
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2003
4	AutoantibodiesIBA 11/2011 - 06/2007
3	AntigensIBA 05/2018 - 06/2003
3	InterleukinsIBA 01/2016 - 05/2013
2	Immunoglobulin M (IgM)IBA 10/2020 - 07/2020
2	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2015 - 01/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2014 - 05/2013
2	DesminIBA 05/2011 - 12/2006
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2008 - 06/2007
1	ReaginsIBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Vorinostat FDA Link 10/2023
1	Antifungal AgentsIBA 07/2023
1	Terbinafine (Lamisil)FDA LinkGeneric 07/2023
1	dupilumabIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 05/2018
1	Nuclear RNAIBA 05/2018
1	Omalizumab (Xolair)FDA Link 02/2018
1	Conditioned Culture MediaIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Interleukin-22 (IL-22)IBA 01/2016
1	Tryptophan (L-Tryptophan)FDA Link 01/2015
1	CytokinesIBA 01/2014
1	Retinaldehyde (Retinal)IBA 01/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2012
1	XenobioticsIBA 01/2012
1	DioxinsIBA 01/2012
1	EnzymesIBA 01/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2012
1	EpitopesIBA 11/2011
1	Thymic Stromal LymphopoietinIBA 09/2011
1	Infliximab (Remicade)FDA Link 09/2011
1	PlectinIBA 05/2011
1	Apolipoproteins AIBA 07/2008
1	oxidized low density lipoproteinIBA 07/2008
1	Amyloid (Amyloid Fibrils)IBA 06/2007
1	C-Reactive ProteinIBA 06/2007
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2007
1	Serine (L-Serine)FDA Link 12/2006
1	Desmoplakins (Desmoplakin)IBA 12/2006
1	CollagenIBA 01/2004
1	Recombinant ProteinsIBA 06/2003
1	Amino Acids FDA Link 06/2003
1	AutoantigensIBA 06/2003

Therapy/Procedure

3	Therapeutics 05/2018 - 07/2012